"This simple microbial compound could work as a standalone therapy, or in synergy with existing treatments," Le Poole said.

or in synergy with existing treatments,” Le Poole said. In 2022, the FDA approved the first re-pigmentation therapy for vitiligo: Opzelura (ruxolitinib) cream. Clinical trials found that only 30 ...

In a phase 2 clinical trial, researchers examined baricitinib and NB-UVB in adults with severe vitiligo in the dermatology ...

A few days ago, millions around the world cheered when the US Food and Drug Administration (FDA) approved a treatment for vitiligo - a topical cream that can restore pigment with unprecedented ...

There is no cure for vitiligo, but there are a variety of innovative treatments that your doctor may prescribe once you've been diagnosed. It's a really exciting time to be treating vitiligo ...

Medically reviewed by Jamin Brahmbhatt, MDVitiligo on the penis occurs when patches of skin change color, just as they can on ...

The Janus kinase inhibitor baricitinib, in combination with narrowband ultraviolet B therapy, improved vitiligo, according to ...

If you’re under age 12, we don’t have any drug that is specifically indicated,” Dr. Lawrence F. Eichenfield said.

Intrinsic alterations in the skin of patients with vitiligo include a thicker epidermis with a reduced number of basal melanocytes and the presence of degenerated keratinocytes with swollen ...

Combining baricitinib with narrowband UVB phototherapy led to significant repigmentation and enhanced quality of life in ...

Discover a recent study that evaluated the efficacy and safety of combining baricitinib, with narrowband UV-B phototherapy in adults with severe, active, nonsegmental vitiligo.